Azenta, Inc. AZTA 深 沪
交易中 05-18 10:44:07 美东时间
16.41
+0.390
+2.43%
华盛通- 最 高16.71
- 今 开16.12
- 成交量 13.62万股
- 最 低 15.93
- 昨 收 16.02
- 总市值 7.56亿
- 52周最高 41.73
- 市盈率 静 --
- 换手率 0.30%
- 52周最低 15.93
- 委 比 -32.20%
- 总股本 4609.28万
- 历史最高 124.69
- 量 比 0.71
- 振 幅 4.87%
- 历史最低 3.92
- 每 手 1
- 风险率 4.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
Needham Maintains Buy on Azenta, Lowers Price Target to $33
Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $44 to $33.
05-07 04:08
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wedn...
05-07 01:05
Azenta shares are trading lower after the company reported worse-than-expected Q2 financial results and issued FY26 sales guidance below estimates.
Azenta shares are trading lower after the company reported worse-than-expected ...
05-06 22:29
财报速睇 | Azenta, Inc. 2026财年Q1营收1.45亿美元，同比增长1.0%；归母净利润亏损1.57亿美元，同比亏损扩大693.4%
华盛资讯5月6日讯，Azenta, Inc.公布2026财年Q1业绩，公司Q1营收1.45亿美元，同比增长1.0%，归母净利润亏损1.57亿美元，同比亏损扩大693.4%。
05-06 07:09
Azenta Sees FY2026 Sales $603.000M-$621.000M vs $623.837M Est
Azenta (NASDAQ:AZTA) sees FY2026 sales of $603.000 million-$621.000 million vs $623.837 million analyst estimate.
05-06 05:43
Azenta Q2 Adj. EPS $0.08 Misses $0.12 Estimate, Sales $145.000M Miss $148.740M Estimate
Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.12 by 33.33 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same
05-06 05:07
Azenta (AZTA) Stock Drops 13% After-Hours — What's Happening?
Azenta stock falls after-hours following SEC Form 3 filing showing no beneficial ownership.
04-17 13:46
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Psyence Biomedical (NASDAQ:PBM) shares increased by 63.4% to $9.59 dur...
04-17 05:05
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
